Table 1 Resistant determinants and sources of multidrug-resistant clinical isolates of Acinetobacter baumannii
Isolate | Properties | Isolate source |
|---|---|---|
AB 19606 | Antibiotic Susceptible type Strain. | National Collection of type cultures |
AB 14 | MDR PFGE defined UK OXA-23 clone 1 OXA-23-like carbapenemase producer. | Dr J Turton, Public Health England, Colindale, UK |
AB 16 | MDR PFGE defined UK OXA-23 clone 2 OXA-23 carbapenemase producer. | Dr J Turton, Public Health England, Colindale, UK |
AB 186 | MDR PFEG defined UK ‘burn’ strain, OXA-23 producer. | Dr J Turton, Public Health England, Colindale, UK |
AB 202 | Tigecycline-resistant strain UK OXA-23 clone 1 isolate. | Barts Health NHS Trust, London, UK |
AB 205 | Colistin resistant UK OXA-23 clone 1 isolate. | Barts Health NHS Trust, London, UK |
AB 292 | MDR PFGE-defined OXA-23-like carbapenemase producer. | Barts Health NHS Trust, London, UK |
AB 306 | MDR NDM-1 carbapenemase producer. | Barts Health NHS Trust, London, UK |
AB 308 | MDR NDM-2 carbapenemase producer. | S. Gottig, Goethe Universistat, Frankfurt, Germany |